TC-1 tumours are easily prevented or controlled by T cell responses to one immunodominant H-2Db–restricted E7 epitope, RAHYNIVTF, which may constitute more than 22% of the entire CD8+ T cell compartment45–48. This evidence concerns the gene CD8A and neoplasm.